Elevance Health Currently Up Eight Consecutive Days, on Track for Longest Winning Streak Since October 2020 — Data Talk
Elevance Health, Inc. (ELV) is currently at $495.14, up $2.79 or 0.57%
--Would be highest close since April 13, 2023, when it closed at $496.20
--Currently up eight consecutive days; up 6.57% over this period
--Longest winning streak since Oct. 5, 2020, when it rose for eight straight trading days
--Best eight day stretch since the eight days ending July 27, 2023, when it rose 7.67%
--Up 5% month-to-date; on pace for best month since Nov. 2023, when it rose 6.53%
--Up 5% year-to-date
--Down 9.44% from its all-time closing high of $546.77 on Oct. 31, 2022
--Down 0.73% from 52 weeks ago (Feb. 1, 2023), when it closed at $498.77
--Down 0.73% from its 52-week closing high of $498.77 on Feb. 1, 2023
--Up 19.56% from its 52-week closing low of $414.13 on July 12, 2023
--Traded as high as $496.78
--Up 0.9% at today's intraday high
All data as of 11:27:10 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
January 31, 2024 11:45 ET (16:45 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing